HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors
| Autor: | Cuppens, Kristof, Baas, Paul, Geerdens, Ellen, Cruys, Bert, Froyen, Guy, Decoster, Lynn, Thomeer, Michiel, Maes, Brigitte |
|---|---|
| Zdroj: | In Lung Cancer August 2022 170:1-10 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect